Coherex Medical Revenue and Competitors

SLC, UT USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Coherex Medical's estimated annual revenue is currently $6.8M per year.(i)
  • Coherex Medical's estimated revenue per employee is $251,000

Employee Data

  • Coherex Medical has 27 Employees.(i)
  • Coherex Medical grew their employee count by -34% last year.

Coherex Medical's People

NameTitleEmail/Phone
1
Regional Site ManagerReveal Email/Phone
2
Senior Clinical Research ManagerReveal Email/Phone
3
Sr. Production PlannerReveal Email/Phone
4
[email protected] mReveal Email/Phone
5
Production EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$94.6M37728%N/AN/A
#2
$16.8M67-17%N/AN/A
#3
$485.4M19347%N/AN/A
#4
$43.7M17415%N/AN/A
#5
$75M19243%$12.8MN/A
#6
$6M24-8%N/AN/A
#7
$7.3M29-22%N/AN/A
#8
$38.4M1533%N/AN/A
#9
$174.4M6959%N/AN/A
#10
$6.8M27-34%N/AN/A
Add Company

What Is Coherex Medical?

Coherex Medical is focused on the development and commercialization of a unique device for the treatment of patients diagnosed with atrial fibrillation and at risk for stroke. Our Goals are to Provide: 1. A Safe & Effective Alternative for Patients at Risk of Stroke. 2. Physicians with a device that is easy to use 3. Enhanced Confidence through Clinical Outcomes

keywords:N/A

N/A

Total Funding

27

Number of Employees

$6.8M

Revenue (est)

-34%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Coherex Medical News

2022-04-20 - Atrial Fibrillation Market Competitive Insights and ...

Biosense Webster, Inc. acquired Coherex Medical, Inc. (U.S.), which helped Biosense Webster, Inc. to strengthen its medical devices product...

2022-04-17 - Globaler Verschluss des linken Vorhofohrs (LAA ...

... Verschluss des linken Vorhofohrs (LAA) Marktnachfrage und zukünftige Wachstumsanalyse 2022–2029 | Coherex Medical, Abbott, Occlutech.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M39-7%N/A
#2
$14.9M5721%N/A
#3
$8.2M5911%$4M
#4
$14.5M642%N/A
#5
$15.8M65-4%N/A